Friday, September 18

Browsing: immunomodulator

General

Tumor DNA clearance reaches 39% in novel immunomodulator and ADC combination

By Healthcare Propulsion StaffSeptember 12, 20260

The investigational combination of pumitamig and elfetabart drozuntecan (elfe-D) demonstrated a manageable safety profile and encouraging early antitumor activity in…

What's Hot

Innovative synthetic artificial skin gives young double amputee his childhood back

Breast density clue for cancer risk

Healthcare’s Silent Risk: Fragmented Communications are Breaking Your Care Model

Browsing: immunomodulator

Tumor DNA clearance reaches 39% in novel immunomodulator and ADC combination

Microplastics transport toxins and antibiotic resistance across ecosystems

ART-conceived children show reassuring long-term health outcomes

New study uncovers bacterial route to testosterone production

Switchboard Health Acquires Livara Health to Integrate Value-Based Musculoskeletal Care

Innovative synthetic artificial skin gives young double amputee his childhood back

Breast density clue for cancer risk

Healthcare’s Silent Risk: Fragmented Communications are Breaking Your Care Model

Keys to Ensuring Data Privacy, Security, and Regulatory Compliance in Consumer-Facing Healthcare Applications

Our Picks

Innovative synthetic artificial skin gives young double amputee his childhood back

Breast density clue for cancer risk

Subscribe to Updates

What's Hot

Browsing: immunomodulator

Subscribe to Updates